U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07409922) titled 'Study of Single and Multiple Ascending Doses of KR23343 in Healthy Adult Participants' on Feb. 02.
Brief Summary: This is a Phase I, single-center trial to assess the safety, tolerability, PK and food effect of KR23343 in healthy volunteers. The study will be conducted in 3 sequential stages:
Stage 1: Single-Ascending-Dose (SAD) study A randomized, double-blind, placebo-controlled, dose-escalation study to assess the safety, tolerability, and PK of single ascending doses of KR23343.
Stage 2: Food-Effect (FE) study An open-label, randomized, two-period, two-sequence crossover study to evaluate the effect of food on the PK of a sing...